Showing results (1681-1690 of 1,795) with videos related to

Sort By:
Pageof 180
Journal of Hepatology|June 16, 2023
Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantationPeder Rustøen Braadland, Annika Bergquist, Martin Kummen, et al.
PNAS Nexus|December 11, 2023
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal deliverySopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre studyElisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Cardiovascular Research|March 23, 2023
VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive ratsAnne-Maj Samuelsson, Theda Ulrike Patricia Bartolomaeus, Harithaa Anandakumar, et al.
Hepatology (Baltimore, Md.)|November 23, 2020
Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic DecompensationOmar Y Mousa, Brian D Juran, Bryan M McCauley, et al.
Journal of Hepatology|April 19, 2026
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitisPeder R Braadland, Ahmad H Ali, Philip Puchas, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2015
Rare variants at 16p11.2 are associated with common variable immunodeficiencyS Melkorka Maggadottir, Jin Li, Joseph T Glessner, et al.
Viruses|April 27, 2024
Hepatitis E Virus Infection in Voluntary Blood Donors in the Russian FederationIlya A Potemkin, Karen K Kyuregyan, Anastasia A Karlsen, et al.
Gut|July 14, 2016
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitisSebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, et al.
Pageof 180